Adherence to self-administered biologic disease-modifying antirheumatic drugs across health-system specialty pharmacies

by Canfield, S., Carter, J., Choi, L., Cowgill, N., Declercq, J., Dura, J., Gazda, N.P, Gerzenshtein, L., Kehasse, A., Lach, M., Lee, J., Lewis, K., Lounsbery, B., Mccarthy, K., Ortega, M., Shah, R., Sokos, L., Stutsky, M., Thomas, K.C, Thomas, T.T, Wise, K., Young, J., Zuckerman, A.D
Published 2021

Primary care provider payment models and adherence to anticoagulation in patients with atrial fibrillation

by Gellad, W.F, Guo, J., Hernandez, I., Liang, Q., Newman, T.V, Yang, L.
Published 2021

The patient’s medication access journey: A conceptual framework focused beyond adherence

by Campbell, P.J, Holland, L., Nelson, M.L, Pickering, M.K, Westrich, K.
Published 2021

Cardiovascular risk prediction model and stratification in patients with type 2 diabetes enrolled in a Medicare Advantage plan

by Caplan, E.O, Chiguluri, V., Goss, A., Harvey, R., Hayden, J., Kattan, M.W, Luthra, R., Pimple, P., Prewitt, T.
Published 2021

Using group-based trajectory modeling to characterize the association of past ACEIs/ARBs adherence with subsequent statin adherence patterns among new statin users

by Abughosh, S.M, Majd, Z., Mohan, A.
Published 2021

Adherence to oral oncolytics filled through an internal health-system specialty pharmacy compared with external specialty pharmacies

by Academia, E.C, Jia, L.Y, Lee, J., Mejías-De Jesús, C.M, Patel, C., Stevens, J.S, Yankama, T.
Published 2021

Treatment utilization patterns of newly initiated oral anticancer agents in a national sample of Medicare beneficiaries

by Brown, V.T, Doshi, J.A, Jahnke, J., Li, P., Manz, C.R, Puckett, J.T, Raman, S., Ward, M.A
Published 2021

Validation of EHR medication fill data obtained through electronic linkage with pharmacies

by Adhikari, S., Anzisi, L., Blecker, S., Desai, S.M, Dodson, J.A, Mann, D.M, Pazand, L., Schoenthaler, A.M, Zhang, H.
Published 2021

Factors associated with the frequency of antihypertensive drug adjustments in chronic kidney disease patients: a multicentre, 2-year retrospective study

by Bavanandan, S., Islahudin, F., Lee, F.Y, Makmor-Bakry, M., Wong, H.-S
Published 2021

Characterizing medication management and the role of pharmacists in caring for people living with cystic fibrosis: A work system approach

by Abraham, O., Braun, A., Decker, C., LeMay, S., Nixon, G., Szela, L.
Published 2021

Factors associated with primary nonadherence to newly initiated direct oral anticoagulants in patients with nonvalvular atrial fibrillation

by Ballarin, E., Charlton, A., Ibanez, L., Martinez, L.M.L, Sabate, M., Vidal, X.
Published 2021

Sustained long-term benefits of patient support program participation in immune-mediated diseases: improved medication-taking behavior and lower risk of a hospital visit

by Brixner, D., Davis, M., Fendrick, A.M, Liu, H., Mease, P., Mittal, M., Rubin, D.T
Published 2021

Development of measurable criteria to identify and prioritize patients for inclusion in comprehensive medication management programs within primary care settings

by Bishop, M.A, Chang, H.-Y, Kharrazi, H., Kitchen, C., Shermock, K.M, Weiner, J.P
Published 2021

Evaluation of home medication review for patients with type 2 diabetes mellitus by community pharmacists: A randomised controlled trial

by Hassan, N.W, Karuppannan, M., Mahmud, M., Neoh, C.F, Rahimi, A., Rosli, M.R, Wu, D.B
Published 2021

Prescription drug coverage satisfaction, cost-reducing behavior, and medication nonadherence among Medicare beneficiaries with type 2 diabetes

by He, Q., Ng, B.P, Park, C., Silverman, C.L, Tiu, G.F
Published 2021

Perceived appropriateness of medication adherence incentives

by Garza, K.B, Hansen, R.A, Hastings, T.J, Hohmann, N.S, Jeminiwa, R., Qian, J.
Published 2021

Impact of a diabetes remote monitoring program on medication adherence

by Amelung, K., Carter, C.S, Henderson, R.R, James, R., Munshi, K.D, Shah, B.R
Published 2021

Effect of the ExactCare medication care management model on adherence, health care utilization, and costs

by Chen, A.Y, Liu, H.H, Rose, A.J, Shetty, K.D
Published 2021

Persistence and adherence to ocrelizumab compared with other disease-modifying therapies for multiple sclerosis in U.S. commercial claims data

by Bawa, K., Engmann, N.J, Ng, C.D, Pardo, G., Sheinson, D.
Published 2021

The effects of oral anticancer parity laws on out-of-pocket spending and adherence among commercially insured patients with chronic myeloid leukemia

by Brown, J.D, Raju, A., Schroader, B., Spargo, A., Squires, P., Yost, C.
Published 2021